A huggable device can reduce the stress of calling an unfamiliar person on the phone for individuals with ASD.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 10 04 2021
accepted: 30 06 2021
entrez: 23 7 2021
pubmed: 24 7 2021
medline: 5 11 2021
Statut: epublish

Résumé

Individuals with autism spectrum disorders (ASD) are often not comfortable during mobile-phone conversations with unfamiliar people. "Hugvie" is a pillow with a human-like shape that has been designed to provide users with the tactile sensation of hugging another person during phone conversations to promote feelings of comfort and trust in the speaker toward their conversation partners. Our primary aim was to examine whether physical contact by hugging a Hugvie could reduce the stress of speaking with an unfamiliar person on the phone in individuals with ASD. We enrolled 24 individuals and requested them to carry out phone conversations either using only a mobile phone or using a mobile phone along with the Hugvie. All participants in both groups completed questionnaires designed to evaluate their self-confidence while talking on the phone, and also provided salivary cortisol samples four times each day. Our analysis revealed that the medium of communication was a significant factor, indicating that individuals with ASD who spoke with an unfamiliar person on the phone while hugging a Hugvie had stronger self-confidence and lower stress levels than those who did not use Hugvie. Hence, we recommend that huggable devices be used as adjunctive tools to support individuals with ASD during telephonic conversations with unfamiliar people.

Identifiants

pubmed: 34297735
doi: 10.1371/journal.pone.0254675
pii: PONE-D-21-11945
pmc: PMC8301655
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0254675

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Child Psychol Psychiatry. 2015 Oct;56(10):1118-26
pubmed: 25626926
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Autism Dev Disord. 2011 Apr;41(4):505-11
pubmed: 20640592
J Autism Dev Disord. 2016 Oct;46(10):3232-41
pubmed: 27448580
Res Autism Spectr Disord. 2012 Winter;6(1):337-344
pubmed: 22059092
Autism. 2009 May;13(3):215-28
pubmed: 19369385
Psychol Assess. 2016 Feb;28(2):214-25
pubmed: 26011476
Mol Autism. 2014 Apr 24;5:29
pubmed: 24791196
Mol Autism. 2010 Jun 17;1(1):10
pubmed: 20678260
Front Behav Neurosci. 2012 Aug 07;6:51
pubmed: 22891054
Front Psychol. 2016 Apr 19;7:510
pubmed: 27148119
Sci Rep. 2013 Oct 23;3:3034
pubmed: 24150186
Brain Cogn. 2006 Jun;61(1):5-13
pubmed: 16500009
J Autism Dev Disord. 2017 Aug;47(8):2425-2433
pubmed: 28534141
Brain Res. 2007 Jun 18;1154:116-23
pubmed: 17498672
J Anxiety Disord. 2002;16(6):661-73
pubmed: 12405524
Neuropsychobiology. 1989;22(3):150-69
pubmed: 2485862
Neurosci Biobehav Rev. 2010 Feb;34(2):246-59
pubmed: 18992276
Front Psychiatry. 2015 Apr 21;6:58
pubmed: 25954210
Autism Res. 2014 Feb;7(1):4-16
pubmed: 24150989
Front Psychol. 2016 Apr 19;7:537
pubmed: 27148144
J Appl Psychol. 2006 Mar;91(2):446-54
pubmed: 16551195
J Autism Dev Disord. 2010 Jan;40(1):112-22
pubmed: 19644746
J Neurophysiol. 2018 Nov 1;120(5):2423-2429
pubmed: 30133382
J Autism Dev Disord. 2010 Aug;40(8):937-45
pubmed: 20108030
J Neurodev Disord. 2013 Nov 11;5(1):32
pubmed: 24216056
Psychosom Med. 1996 Sep-Oct;58(5):447-58
pubmed: 8902896
Pediatr Res. 2011 May;69(5 Pt 2):48R-54R
pubmed: 21289533
J Consult Clin Psychol. 2000 Apr;68(2):322-30
pubmed: 10780133
Front Psychiatry. 2017 Sep 11;8:169
pubmed: 28955254
Sci Rep. 2016 Dec 23;6:39718
pubmed: 28009014
Cyberpsychol Behav Soc Netw. 2014 Nov;17(11):702-8
pubmed: 25405782
J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):344-351.e3
pubmed: 28335879
Autism Res. 2012 Aug;5(4):231-44
pubmed: 22447729
J Autism Dev Disord. 2007 Mar;37(3):491-500
pubmed: 16944324
Behav Brain Sci. 1997 Dec;20(4):723-42; discussion 743-67
pubmed: 10097009
Front Integr Neurosci. 2013 Jul 17;7:49
pubmed: 23882192
Shinrigaku Kenkyu. 2004 Apr;75(1):78-84
pubmed: 15724518
Mod Probl Pharmacopsychiatry. 1987;22:141-73
pubmed: 2885745
Mol Autism. 2012 Nov 17;3(1):13
pubmed: 23158965
J Autism Dev Disord. 2008 Jan;38(1):127-37
pubmed: 17415630
J Autism Dev Disord. 2003 Dec;33(6):631-42
pubmed: 14714932
J Autism Dev Disord. 2013 Oct;43(10):2405-17
pubmed: 23430177
Dtsch Arztebl Int. 2012 Apr;109(15):276-81
pubmed: 22567063
J Autism Dev Disord. 2016 May;46(5):1528-37
pubmed: 24091471
Autism. 2009 Nov;13(6):583-98
pubmed: 19933765
PLoS One. 2011;6(6):e20835
pubmed: 21695147
J Child Psychol Psychiatry. 2002 Mar;43(3):307-25
pubmed: 11944874
J Child Psychol Psychiatry. 2002 Mar;43(3):327-42
pubmed: 11944875
Autism. 2017 Apr;21(3):333-343
pubmed: 27154909

Auteurs

Hidenobu Sumioka (H)

Hiroshi Ishiguro Laboratories, Advanced Telecommunications Research Institute International, Kyoto, Japan.

Hirokazu Kumazaki (H)

Department of Preventive Intervention for Psychiatric Disorders, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.
Research Center for Child Mental Development, Kanazawa University, Kanazawa, Ishikawa, Japan.
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Taro Muramatsu (T)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Yuichiro Yoshikawa (Y)

Department of Systems Innovation, Graduate School of Engineering Science, Osaka University, Osaka, Japan.

Hiroshi Ishiguro (H)

Department of Systems Innovation, Graduate School of Engineering Science, Osaka University, Osaka, Japan.

Haruhiro Higashida (H)

Research Center for Child Mental Development, Kanazawa University, Kanazawa, Ishikawa, Japan.

Teruko Yuhi (T)

Research Center for Child Mental Development, Kanazawa University, Kanazawa, Ishikawa, Japan.

Masaru Mimura (M)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH